Replies to post #73193 on PharmaCyte Biotech Inc (PMCB)

[1234jklm]

And one more thing you missed

Austrianovas previous partner has just signed an agreement with j&j for their viral delivery service.

[stanchjojoina]

thank u for your input it helps adding to my DD

[rudygerner]

Here is the reality: https://www.facebook.com/austrianova/photos/a.806632359368640.1073741832.747212361977307/1616942508337617/?type=3&theater

This is posted on Austrianova's FB page. Austrianova has a new partner. We now know this definitively.

A new partner is very significant for PharmaCyte, Austrianova and Cell-in-a-Box®.

PharmaCyte Biotech owns the exclusive worldwide rights to use the Cell-in-a-Box® encapsulation technology as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer, are being built.

More noteworthy from a forward revenue standpoint, PharmaCyte also owns the exclusive worldwide rights to use the Cell-in-a-Box® technology for the development of a treatment for Type 1 & Type 2 diabetes. It makes sense for the world's largest pharmaceutical company, Johnson & Johnson, to want the world's best encapsulation technology, Cell-in-a-Box®, to treat one of the world's largest health problems: diabetes.